Government Shutdown Ends with Key Wins for Hearing Health

The recently passed federal funding agreement ending the government shutdown includes important provisions that strengthen hearing healthcare and improve patient access to services. Notably, the legislation provides $18.18 million for Early Hearing Detection and Intervention (EHDI) programs, representing a $1 million increase over fiscal year 2025 funding levels. The bill also includes pharmacy benefit manager (PBM) reform provisions aimed at increasing transparency and reducing healthcare costs.

EHDI programs play a critical role in ensuring newborns and young children receive timely hearing screenings, diagnostic services, and early intervention. Early identification of hearing loss is essential to supporting speech, language, and social development, and strong federal investment helps states maintain tracking systems, improve follow-up care, and expand services in underserved communities. The funding increase reflects continued bipartisan recognition of the importance of early hearing healthcare. In addition to public health investments, the legislation advances PBM reform measures designed to address concerns about drug pricing practices and lack of transparency within the prescription drug supply chain. These provisions aim to improve oversight, reduce spread pricing practices, and provide greater clarity around medication costs for patients and providers. For individuals with hearing and balance disorders who rely on prescription medications, these reforms may help improve affordability and access to necessary treatments.

The Academy is thrilled in the increased investment in EHDI and efforts to improve healthcare affordability represent meaningful progress for patients, families, and hearing healthcare providers.